Search research articles
Contact Us
Filters
Showing results (71-80 of 89) with videos related to
Page
of 9
Sort By:
Prostate Cancer and Prostatic Diseases
|
September 27, 2024
Evaluating 4Kscore's role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS score
Helen Y Hougen, Isildinha M Reis, Sunwoo Han, et al.
Clinical and Translational Radiation Oncology
|
January 23, 2025
Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey
Jennifer Le Guévelou, Paul Sargos, Piet Ost, et al.
European Urology Oncology
|
November 14, 2024
Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials
Krishnan R Patel, Paul L Nguyen, James A Proudfoot, et al.
BJU International
|
February 27, 2026
Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST)
Ankur Malpani, Jonathan T Ryan, Hui Yu, et al.
Practical Radiation Oncology
|
July 17, 2024
Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: A Case-Based Radiosurgery Society Practice Guide
Andrew B Barbour, Rituraj Upadhyay, August C Anderson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 6, 2022
Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trial
Marcus Beck, Manfred Sassowsky, Sämi Schär, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 13, 2022
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus
Thomas Zilli, Vérane Achard, Alan Dal Pra, et al.
Prostate Cancer and Prostatic Diseases
|
April 2, 2020
Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier
Jeffrey J Tosoian, Samuel R Birer, R Jeffrey Karnes, et al.
European Urology
|
September 18, 2024
Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer
Adam B Weiner, Raag Agrawal, Nicholas K Wang, et al.
Cancer Genetics
|
September 22, 2021
Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE)
Nishwant Swami, William L Hwang, Jimmy A Guo, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 89) with videos related to
Sort By:
Page
of 9
Prostate Cancer and Prostatic Diseases
|
September 27, 2024
Evaluating 4Kscore's role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS score
Helen Y Hougen, Isildinha M Reis, Sunwoo Han, et al.
Clinical and Translational Radiation Oncology
|
January 23, 2025
Urethra-sparing prostate cancer radiotherapy: Current practices and future insights from an international survey
Jennifer Le Guévelou, Paul Sargos, Piet Ost, et al.
European Urology Oncology
|
November 14, 2024
Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials
Krishnan R Patel, Paul L Nguyen, James A Proudfoot, et al.
BJU International
|
February 27, 2026
Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST)
Ankur Malpani, Jonathan T Ryan, Hui Yu, et al.
Practical Radiation Oncology
|
July 17, 2024
Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma: A Case-Based Radiosurgery Society Practice Guide
Andrew B Barbour, Rituraj Upadhyay, August C Anderson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 6, 2022
Adherence to Contouring and Treatment Planning Requirements Within a Multicentric Trial: Results of the Quality Assurance of the SAKK 09/10 trial
Marcus Beck, Manfred Sassowsky, Sämi Schär, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 13, 2022
Recommendations for radiation therapy in oligometastatic prostate cancer: An ESTRO-ACROP Delphi consensus
Thomas Zilli, Vérane Achard, Alan Dal Pra, et al.
Prostate Cancer and Prostatic Diseases
|
April 2, 2020
Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier
Jeffrey J Tosoian, Samuel R Birer, R Jeffrey Karnes, et al.
European Urology
|
September 18, 2024
Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer
Adam B Weiner, Raag Agrawal, Nicholas K Wang, et al.
Cancer Genetics
|
September 22, 2021
Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE)
Nishwant Swami, William L Hwang, Jimmy A Guo, et al.
Page
of 9